Overexpression and mutations of the three NSD family members (NSD1, NSD2, and NSD3) have been linked to several types of cancers, including lung cancer, breast cancer, prostate cancer, acute myeloid leukaemia, acute lymphoblastic leukaemia, and multiple myeloma. This evidence concerns the gene SLC17A5 and lung carcinoma.